Busulfan Injection is indicated for use in combination with other chemotherapeutic agents and/or radiotherapy as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation including acute lymphocytic leukemia, acute non-lymphocytic leukemia, acute myeloid leukemia, chronic myelogenous leukemia (CML), non-Hodgkin's lymphoma, Hodgkin's disease, multiple myeloma and myelodysplastic syndrome.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
